Evaluating coronary artery disease in patients with diabetes
Diabetes Follow-up Study for REduction of cardiovAscular outcoMes: a Coronary Computed Tomographic Angiography Cohort Study
Asan Medical Center · NCT05801432
This study is trying to see how coronary artery disease develops over time in people with diabetes by using special heart scans and gathering health information.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 511 (estimated) |
| Ages | 19 Years and up |
| Sex | All |
| Sponsor | Asan Medical Center (other) |
| Locations | 1 site (Seoul) |
| Trial ID | NCT05801432 on ClinicalTrials.gov |
What this trial studies
This study aims to assess the natural progression of coronary atherosclerosis in patients with diabetes mellitus using coronary computed tomographic angiography (CCTA). It involves evaluating patients who underwent initial CCTA at the Diabetes Center of the Asan Medical Center from February 2008 to June 2012, with follow-up CCTA based on physician orders. The study will collect demographic data, medical history, cardiovascular risk factors, and laboratory results to identify risk factors associated with coronary atherosclerosis in this population.
Who should consider this trial
Good fit: Ideal candidates are asymptomatic patients aged 19 years or older with type 2 diabetes who had an initial CCTA at the Asan Medical Center.
Not a fit: Patients with significant renal impairment, a history of severe allergic reactions to contrast media, or those unable to undergo follow-up CCTA may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance understanding of coronary artery disease in diabetic patients, leading to better prevention and treatment strategies.
How similar studies have performed: Other studies have shown success in evaluating coronary atherosclerosis in diabetic populations, indicating that this approach is supported by previous research.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 19 years or older * Asymptomatic patients with type 2 DM who had undergone initial CCTA evaluation at the Diabetes Center of the Asan Medical Center between February 2008 and June 2012 * Willing and able to provide informed written consent Exclusion Criteria: * Blood test results that the Creatinine level exceeds 1.5 mg/dL * A person with a history of anaphylaxis or allergic shock associated with a contrast medium * Pregnant women * Unable to undergo follow-up CCTA * Uninterpretable CCTA
Where this trial is running
Seoul
- Asan Medical Center — Seoul, South Korea (RECRUITING)
Study contacts
- Study coordinator: Ji Sue HONG, RN
- Email: sue5165@naver.com
- Phone: 82 2-2045-3798
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Diabetes Mellitus